V Wealth Advisors’s Protara Therapeutics TARA Stock Holding History

V Wealth Advisors’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-31	Closed	-$2K	–	641
2017 Q2	$2K	Buy	+31	New	+$1.74K	﹤0.01%	761

Other funds holding TARA

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

V Wealth Advisors's TARA Position: Q3 2017 in Review

V Wealth Advisors sold out of Protara Therapeutics (TARA) in Q3 2017, closing a stake of 31 shares — an estimated $2K sold.

V Wealth Advisors first reported a position in TARA in Q2 2017 and held it in 1 quarter. The position peaked at $2K in Q2 2017. 25 funds tracked by Wall St. Rank hold TARA as of Q3 2017.

V Wealth Advisors reported no remaining Protara Therapeutics position as of Q3 2017 after selling out during the quarter.
V Wealth Advisors sold 31 Protara Therapeutics shares in Q3 2017, an estimated $2K.
V Wealth Advisors first reported a position in Protara Therapeutics in Q2 2017 and held it in 1 quarter.
V Wealth Advisors's Protara Therapeutics position peaked at $2K in Q2 2017.
25 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2017.

Based on V Wealth Advisors's 13F filing for Q3 2017, filed 12 Oct 2017.